Boston settles Guidant spat with JNJ and emerges not too dented
This article was originally published in Clinica
Executive Summary
Boston Scientific and Johnson & Johnson have finally buried the hatchet in their longstanding dispute ignited by an intense bidding war for cardiovascular device firm Guidant in late 2005.